Literature DB >> 8065529

The functional role of molecular forms of acetylcholinesterase in neuromuscular transmission.

R W Busker1, J J Zijlstra, H J van der Wiel, H P van Helden.   

Abstract

The severity of poisoning following acetylcholinesterase (AChE) inhibition correlates weakly with total AChE activity. This may be partly due to the existence of functional and non-functional pools of AChE. AChE consists of several molecular forms. The aim of the present study was to investigate which of these forms will correlate best with neuromuscular transmission (NMT) remaining after partial inhibition of this enzyme. Following sublethal intoxication of rats with the irreversible AChE inhibitor soman, diaphragms were isolated after 0.5 or 3 h. It appeared that at 3 h after soman poisoning the percentage of G1 increased, while those of G4 and A12 decreased. NMT was inhibited more strongly than in preparations obtained from the 0.5 h rats with the same level of AChE inhibition, but with a normal ratio of molecular forms. NMT correlated positively with G4 as well as with A12, but inversely with G1. In vitro inhibition with the charged inhibitors DEMP and echothiophate resulted in higher levels of total AChE, relatively less G1 and more G4 and A12 than after incubation with soman, but led to less NMT. Treatment of soman-intoxicated rats with the reactivating compound HI-6 resulted in preferential reactivation of A12, persisting low levels of G1 and concurrent recovery of NMT as compared with saline-treated soman controls with equal total AChE activity. Apparently, in rat diaphragm G4 and A12 are the functional AChE forms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8065529     DOI: 10.1007/bf00967711

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  29 in total

Review 1.  Distribution and anchoring of molecular forms of acetylcholinesterase.

Authors:  N C Inestrosa; A Perelman
Journal:  Trends Pharmacol Sci       Date:  1989-08       Impact factor: 14.819

2.  Effects of organophosphorus anticholinesterases on nicotinic receptor ion channels at adult mouse muscle endplates.

Authors:  J E Tattersall
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

3.  Swimming training increases the G4 acetylcholinesterase content of both fast ankle extensors and flexors.

Authors:  V Gisiger; S Sherker; P F Gardiner
Journal:  FEBS Lett       Date:  1991-01-28       Impact factor: 4.124

4.  On the development of behavioral tolerance to organophosphates. II: Neurophysiological aspects.

Authors:  B P Melchers; H P van Helden
Journal:  Pharmacol Biochem Behav       Date:  1990-02       Impact factor: 3.533

5.  Efficacy of a combination of acetylcholinesterase reactivators, HI-6 and obidoxime, against tabun and soman poisoning of mice.

Authors:  J G Clement; J D Shiloff; C Gennings
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

6.  Therapeutic efficacy of HI-6 in soman-poisoned marmoset monkeys.

Authors:  H P van Helden; H J van der Wiel; J de Lange; R W Busker; B P Melchers; O L Wolthuis
Journal:  Toxicol Appl Pharmacol       Date:  1992-07       Impact factor: 4.219

7.  Histochemical and cytochemical localization of acetylcholinesterase in the cerebellar cortex of the chicken.

Authors:  V Siripholvat; T Watanabe; T Tomita
Journal:  Jikken Dobutsu       Date:  1988-10

8.  Muscle acetylcholinesterase adapts to compensatory overload by a general increase in its molecular forms.

Authors:  B J Jasmin; P F Gardiner; V Gisiger
Journal:  J Appl Physiol (1985)       Date:  1991-06

9.  Trophic regulation of acetylcholinesterase isoenzymes in adult mammalian skeletal muscles.

Authors:  H L Fernandez; C A Hodges-Savola
Journal:  Neurochem Res       Date:  1992-01       Impact factor: 3.996

10.  Prompt recovery from severe cholinesterase-inhibitor poisoning--remarks on classification and therapy of organophosphate poisoning.

Authors:  V De Wilde; D Vogelaers; F Colardyn
Journal:  Klin Wochenschr       Date:  1990-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.